NUZ 6.25% 22.5¢ neurizon therapeutics limited

PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-1423

  1. 475 Posts.
    lightbulb Created with Sketch. 286
    Understand your frustration, however this is a microstock completing clinical trials with a sheep dip compound.
    Until there is a commercial outcome, the share price
    will be haphazard.
    If outcomes are poor, this could go to 1c or less.
    If outcomes are positive, this could reach $1 or more.
    As a top 10 holder I'm happy to wait for a commercial result, which I feel will be positive. I don’t really care for communication not based on a result.
    If patience isnt a virtue, it needs to be handled or sell out if you're frustrated.
    I would suggest thst we have never been closer to commercial outcomes, so I'm happy to wait. Even though I would have preferred faster results!



 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.